• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Carrie Stricker on Why Clinician Voices Are Needed in Health IT Development

Video

The most transformative software companies are those that have seized the opportunity to incorporate clinician and patient voices into the design of their health IT tools, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

The most transformative software companies are those that have seized the opportunity to incorporate clinician and patient voices into the design of their health information technology (IT) tools, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

Transcript (slightly modified)

What are some oncology challenges that can be turned into opportunities with health IT?

Well, it’s interesting, coming off this panel one of the big things that we talked about is workflow. That so much of what health IT is available to clinicians and care teams right now has not been designed with attention to workflow at the point of care. And all the panel members today in the “Surmounting IT Challenges” section of the conference today highlighted, myself included, what an opportunity that is.

Suzanne [Belinson] with BlueCross, I think stated it very well [at the Patient-Centered Oncology Care meeting]. She said now it is the companies who have either clinicians at their leadership level and/or who are dedicated to bringing clinicians and care teams in the process of designing software that are really being disruptive in the most positive sense of that term, transforming how health IT supports providers, care teams, and patients and families by bringing their voices into the development and ensuring that they’re a part of the solution of designing and testing and improving these health IT solutions. That’s the crux of it.

Related Videos
Steven Manobianco, MD
Xiaotong Li, PhD, MS, Memorial Sloan Kettering Cancer Center
Dr Amrita Basu
Justin Drake, PhD
Joanna Rhodes, MD, MSCE, director of the lymphoma program at the Rutgers Cancer Institute and the assistant head of lymphoma at Robert Wood Johnson Medical School
Ira Zackon, MD, senior medical director, Ontada
Shayla Bergmann, MD, a clinical professor in pediatric hematology at the Medical University of South Carolina
Erika Hamilton, MD
Ivo Carre, PhD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.